CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD. Blennow K, Diaz-Lucena D, Zetterberg H, Villar-Pique A, et al. J Neurol Neurosurg Psychiatry 2019;90:846-853.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blennow K, Diaz-Lucena D, Zetterberg H, Villar-Pique A, et al. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD. J Neurol Neurosurg Psychiatry 2019;90:846-853.
PMID: 31097472